Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population - PubMed (original) (raw)
Clinical Trial
Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population
Sanneke van Rooden et al. Stroke. 2009 Sep.
Abstract
Background and purpose: Validation of the Boston criteria for the in vivo diagnosis of cerebral amyloid angiopathy (CAA) is challenging, because noninvasive diagnostic tests do not exist. Hereditary cerebral hemorrhage with amyloidosis-Dutch type is an accepted monogenetic model of CAA and diagnosis can be made with certainty based on DNA analysis. The aim of this study was to analyze and refine the existing Boston criteria in patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type.
Methods: We performed T2*-weighted MRI in 27 patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type to assess the presence and location of microbleeds, intracranial hemorrhages, and superficial siderosis. Using the Boston criteria, subjects were categorized as having: no hemorrhages, possible CAA, probable CAA, and hemorrhagic lesions not qualifying for CAA. The sensitivity of the Boston criteria was calculated separately using intracranial hemorrhages only and using intracranial hemorrhages and microbleeds.
Results: The sensitivity of the Boston criteria for probable CAA increased from 48% to 63% when microbleeds were included. For symptomatic subjects only, the sensitivity was 100%. No hemorrhages were identified in the deep white matter, basal ganglia, thalamus, or brainstem. Superficial siderosis, observed in 6 patients, did not increase the sensitivity of the Boston criteria in our study group.
Conclusions: Our data show that using T2*-weighted MRI and including microbleeds increase the sensitivity of the Boston criteria. The exclusion of hemorrhages in the deep white matter, basal ganglia, thalamus, and brainstem does not lower the sensitivity of the Boston criteria.
Similar articles
- Cerebellar hemorrhages in patients with Dutch-type hereditary cerebral amyloid angiopathy.
Voigt S, de Kruijff PC, Koemans EA, Rasing I, van Etten ES, Terwindt GM, van Osch M, van Buchem MA, van Walderveen M, Wermer M. Voigt S, et al. Int J Stroke. 2022 Jul;17(6):637-644. doi: 10.1177/17474930211043663. Epub 2021 Sep 10. Int J Stroke. 2022. PMID: 34427476 Free PMC article. - Brain Deep Medullary Veins on 7T MRI in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
van Harten TW, Heijmans A, van Rooden S, Wermer MJH, van Osch MJP, Kuijf HJ, van Veluw SJ, Greenberg SM, van Buchem MA, van der Grond J, van Walderveen MAA. van Harten TW, et al. J Alzheimers Dis. 2022;90(1):381-388. doi: 10.3233/JAD-220354. J Alzheimers Dis. 2022. PMID: 36120778 Free PMC article. - Early Magnetic Resonance Imaging and Cognitive Markers of Hereditary Cerebral Amyloid Angiopathy.
van Rooden S, van Opstal AM, Labadie G, Terwindt GM, Wermer MJ, Webb AG, Middelkoop HA, Greenberg SM, van der Grond J, van Buchem MA. van Rooden S, et al. Stroke. 2016 Dec;47(12):3041-3044. doi: 10.1161/STROKEAHA.116.014418. Epub 2016 Nov 10. Stroke. 2016. PMID: 27834748 Free PMC article. - MRI for in vivo diagnosis of cerebral amyloid angiopathy: Tailoring artifacts to image hemorrhagic biomarkers.
Boulouis G, Edjlali-Goujon M, Moulin S, Ben Hassen W, Naggara O, Oppenheim C, Cordonnier C. Boulouis G, et al. Rev Neurol (Paris). 2017 Nov;173(9):554-561. doi: 10.1016/j.neurol.2017.09.004. Epub 2017 Oct 4. Rev Neurol (Paris). 2017. PMID: 28987481 Review. - Cerebral amyloid angiopathy-associated intracerebral hemorrhage: pathology and management.
Mehndiratta P, Manjila S, Ostergard T, Eisele S, Cohen ML, Sila C, Selman WR. Mehndiratta P, et al. Neurosurg Focus. 2012 Apr;32(4):E7. doi: 10.3171/2012.1.FOCUS11370. Neurosurg Focus. 2012. PMID: 22463117 Review.
Cited by
- Vascular Cognitive Impairment.
Graff-Radford J. Graff-Radford J. Continuum (Minneap Minn). 2019 Feb;25(1):147-164. doi: 10.1212/CON.0000000000000684. Continuum (Minneap Minn). 2019. PMID: 30707191 Free PMC article. Review. - Diagnostic Utility of Integrated11C-Pittsburgh Compound B Positron Emission Tomography/Magnetic Resonance for Cerebral Amyloid Angiopathy: A Pilot Study.
Chang Y, Liu J, Wang L, Li X, Wang Z, Lin M, Jin W, Zhu M, Xu B. Chang Y, et al. Front Aging Neurosci. 2021 Nov 25;13:721780. doi: 10.3389/fnagi.2021.721780. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34899265 Free PMC article. - Cerebral amyloid angiopathy: a transient ischaemic attack mimic.
Illsley A, Ramadan H. Illsley A, et al. Clin Med (Lond). 2014 Jun;14(3):255-9. doi: 10.7861/clinmedicine.14-3-255. Clin Med (Lond). 2014. PMID: 24889568 Free PMC article. Review. - Young plasma attenuates cognitive impairment and the cortical hemorrhage area in cerebral amyloid angiopathy model mice.
Li N, Zhang X, Gu Z, Su C, Lian H. Li N, et al. Ann Transl Med. 2021 Jan;9(2):147. doi: 10.21037/atm-20-8008. Ann Transl Med. 2021. PMID: 33569449 Free PMC article. - Biopsy During Minimally Invasive Intracerebral Hemorrhage Clot Evacuation.
Lieber AC, McNeill IT, Scaggiante J, Nistal DA, Fowkes M, Umphlett M, Pan J, Roussos P, Mobbs CV, Mocco J, Kellner CP. Lieber AC, et al. World Neurosurg. 2019 Apr;124:e169-e175. doi: 10.1016/j.wneu.2018.12.058. Epub 2018 Dec 24. World Neurosurg. 2019. PMID: 30590212 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical